Deflazacort, Oral

Simple item page
dc.contributor.advisorMitsnefes, Mark
dc.contributor.authorDickinson, Kimberly
dc.contributor.otherChildren's Hospital of Philadelphia
dc.date.accessioned2024-06-10T19:03:22Z
dc.date.available2024-06-10T19:03:22Z
dc.date.created2022-02-01
dc.descriptionThis concept set contains oral deflazacort. There are no combinations. This concept set was generated by taking all descendants of oral deflazacort from the SCDG level. The codeset was reviewed by the PRESERVE BPZ workgroup led by Mark Mitsnefes. This codeset was created as part of the inclusion/exclusion criteria for the cohort of patients for the development and evaluation of EHR-based pediatric blood pressure Z-scores. One of the exclusion criteria was exposure to specific steroids (including oral deflazacort) at any time. This concept set is limited to medications in the RxNorm and RxNorm Extension vocabularies.
dc.description.abstractConcept set intended to identify patients with an exposure to oral Deflazacort.
dc.identifier.urihttps://pedsnet.org/metadata/handle/20.500.14642/527
dc.provenancePreserving Kidney Function in Children with Chronic Kidney Disease (PRESERVE)
dc.publisherPEDSnet
dc.relation.urihttps://github.com/PRESERVE-Coordinating-Center/PRESERVE_Variables/blob/dfe52bdc48cfcfd6b358d4a424b5d39749554025/codesets/drug/rx_deflazacort.csv
dc.rightsa CC-BY Attribution 4.0 License.
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectConcept Set Development::Content Data Model::PEDSnet Data Model
dc.subjectConcept Set Development::Content Data Model::PCORnet Data Model
dc.subjectConcept Set Development::Concept Set Development Strategy::Variable Characterization::Independent Variable
dc.subjectConcept Set Development::Concept Set Development Strategy::Cohort Characterization::Exclusion Criteria
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Brand Pack Name
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Branded Drug
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Clinical Drug
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Branded Drug Form
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Clinical Drug Form
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Branded Drug Component
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Clinical Drug Component
dc.subjectConcept Set Development::Concept Set Evaluation::Clinician Reviewed
dc.subject.meshDeflazacort
dc.subject.meshCorticosteroid
dc.subject.meshSteroid
dc.subject.meshHormone
dc.subject.meshReceptor Agonist
dc.subject.otherRxNorm
dc.subject.otherRxNorm Extension
dc.titleDeflazacort, Oral
dspace.entity.typeConceptSet
local.quality.statusResearch-Ready
local.subject.flatPEDSnet Data Model
local.subject.flatPCORnet Data Model
local.subject.flatIndependent Variable
local.subject.flatExclusion Criteria
local.subject.flatBrand Pack Name
local.subject.flatSemantic Branded Drug
local.subject.flatSemantic Clinical Drug
local.subject.flatSemantic Branded Drug Form
local.subject.flatSemantic Clinical Drug Form
local.subject.flatSemantic Branded Drug Component
local.subject.flatSemantic Clinical Drug Component
local.subject.flatClinician Reviewed
relation.isStudyOfConceptSet6df51ca1-7a01-4551-b1f1-ca70aaf2c5ae
relation.isStudyOfConceptSet.latestForDiscovery6df51ca1-7a01-4551-b1f1-ca70aaf2c5ae

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
rx_2022_02_Deflazacort_V1.csv
Size:
7.3 KB
Format:
Comma-Separated Values
Download

Domains

Medication Concept Sets